Repligen (RGEN) P/E (2010 - 2026)
Repligen (RGEN) P/E from Jun 30, 2010 to Jun 3, 2026. The TTM Repligen (RGEN) P/E is 133.34. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Repligen (RGEN)
| Year | P/E | Change |
|---|---|---|
| 2026 | 133.34 | -29.29% |
| 2025 | 188.57 | -40.66% |
| 2024 | 317.75 | +237.40% |
| 2023 | 94.18 | +66.88% |
| 2022 | 56.43 | -50.40% |
| 2021 | 113.78 | -33.13% |
| 2020 | 170.14 | -16.84% |
| 2019 | 204.60 | +47.09% |
| 2018 | 139.09 | +127.46% |
| 2017 | 61.15 | -59.07% |
| 2016 | 149.39 | +49.92% |
| 2015 | 99.65 | +27.32% |
| 2014 | 78.27 | +190.47% |
| 2013 | 26.95 | +95.32% |
| 2012 | 13.80 | -111.19% |
| 2011 | -123.34 | -237.68% |
| 2010 | 89.58 | N/A |
Comparison Repligen (RGEN) P/E with competitors
Repligen (RGEN) P/E is 133.34.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 0.22 | -99.83% |
| EMBC | Embecta Corp | 1.73 | -98.70% |
| SOLV | Solventum Corp | 9.19 | -93.11% |
| ZJYL | Jin Medical International Ltd | 14.31 | -89.27% |
| PDEX | Pro-Dex Inc (co) | 17.38 | -86.96% |
| UTMD | Utah Medical Products Inc | 19.32 | -85.51% |
| ATR | Aptargroup Inc | 19.33 | -85.50% |
| RMD | Resmed Inc | 19.77 | -85.18% |
| MMSI | Merit Medical Systems Inc | 26.66 | -80.01% |
| ALGN | Align Technology Inc | 27.22 | -79.59% |
| COO | Cooper Companies Inc | 29.86 | -77.61% |
| STVN | Stevanato Group Spa | 29.88 | -77.59% |
| HOLX | Hologic Inc | 30.86 | -76.85% |
| LMAT | Lemaitre Vascular Inc | 34.86 | -73.86% |
| ALC | Alcon Inc | 40.20 | -69.85% |
| WST | West Pharmaceutical Services Inc | 41.29 | -69.03% |
| BDX | Becton Dickinson & Company | 44.61 | -66.55% |
| NEPH | Nephros Inc | 49.38 | -62.97% |
| ISRG | Intuitive Surgical Inc | 49.96 | -62.53% |
| NVST | Envista Holdings Corp | 56.43 | -57.68% |
| BAX | Baxter International Inc | 63.44 | -52.42% |
| ICUI | ICU Medical Inc | 74.28 | -44.29% |
| NNNN | Anbio Biotechnology - Class A | 223.63 | +67.71% |
| WRBY | Warby Parker Inc - Class A | 292.87 | +119.63% |